These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
396 related articles for article (PubMed ID: 28376711)
21. Aspartate aminotransferase to platelet ratio index and sustained virologic response are associated with progression from hepatitis C associated liver cirrhosis to hepatocellular carcinoma after treatment with pegylated interferon plus ribavirin. Ng KJ; Tseng CW; Chang TT; Tzeng SJ; Hsieh YH; Hung TH; Huang HT; Wu SF; Tseng KC Clin Interv Aging; 2016; 11():1035-41. PubMed ID: 27536084 [TBL] [Abstract][Full Text] [Related]
22. Viral eradication reduces all-cause mortality, including non-liver-related disease, in patients with progressive hepatitis C virus-related fibrosis. Tada T; Kumada T; Toyoda H; Kiriyama S; Tanikawa M; Hisanaga Y; Kanamori A; Kitabatake S; Yama T; Tanaka J J Gastroenterol Hepatol; 2017 Mar; 32(3):687-694. PubMed ID: 27577675 [TBL] [Abstract][Full Text] [Related]
23. Long-term follow-up of patients with chronic hepatitis C treated with α-interferon and ribavirin antiviral therapy: clinical and fibrosis impact of treatment response. Cordero-Ruiz P; Carmona-Soria I; Rodríguez-Téllez M; Caunedo-Alvarez A; Quezada-Pacheco RH; Flores-Cucho A; Romero-Gómez M; Vilches-Arenas Á Eur J Gastroenterol Hepatol; 2017 Jul; 29(7):792-799. PubMed ID: 28445251 [TBL] [Abstract][Full Text] [Related]
24. The impact of treatment of hepatitis C with DAAs on the occurrence of HCC. Roche B; Coilly A; Duclos-Vallee JC; Samuel D Liver Int; 2018 Feb; 38 Suppl 1():139-145. PubMed ID: 29427487 [TBL] [Abstract][Full Text] [Related]
25. Effect of addition of statins to antiviral therapy in hepatitis C virus-infected persons: Results from ERCHIVES. Butt AA; Yan P; Bonilla H; Abou-Samra AB; Shaikh OS; Simon TG; Chung RT; Rogal SS; Hepatology; 2015 Aug; 62(2):365-74. PubMed ID: 25847403 [TBL] [Abstract][Full Text] [Related]
26. Epidemiology and natural history of hepatitis C virus infection among children and young people. Modin L; Arshad A; Wilkes B; Benselin J; Lloyd C; Irving WL; Kelly DA J Hepatol; 2019 Mar; 70(3):371-378. PubMed ID: 30496763 [TBL] [Abstract][Full Text] [Related]
27. Long-term cohort study of chronic hepatitis C according to interferon efficacy. Maruoka D; Imazeki F; Arai M; Kanda T; Fujiwara K; Yokosuka O J Gastroenterol Hepatol; 2012 Feb; 27(2):291-9. PubMed ID: 21793911 [TBL] [Abstract][Full Text] [Related]
28. Impact of sustained virological response on the extrahepatic manifestations of chronic hepatitis C: a meta-analysis. Cacoub P; Desbois AC; Comarmond C; Saadoun D Gut; 2018 Nov; 67(11):2025-2034. PubMed ID: 29703790 [TBL] [Abstract][Full Text] [Related]
29. Cure With Interferon-Free Direct-Acting Antiviral Is Associated With Increased Survival in Patients With Hepatitis C Virus-Related Hepatocellular Carcinoma From Both East and West. Dang H; Yeo YH; Yasuda S; Huang CF; Iio E; Landis C; Jun DW; Enomoto M; Ogawa E; Tsai PC; Le A; Liu M; Maeda M; Nguyen B; Ramrakhiani N; Henry L; Cheung R; Tamori A; Kumada T; Tanaka Y; Yu ML; Toyoda H; Nguyen MH Hepatology; 2020 Jun; 71(6):1910-1922. PubMed ID: 31610027 [TBL] [Abstract][Full Text] [Related]
30. Does antiviral therapy prevent hepatocellular carcinoma? Kwon H; Lok AS Antivir Ther; 2011; 16(6):787-95. PubMed ID: 21900710 [TBL] [Abstract][Full Text] [Related]
31. Impact of direct-acting antiviral regimens on mortality and morbidity outcomes in patients with chronic hepatitis c: Systematic review and meta-analysis. Sahakyan Y; Lee-Kim V; Bremner KE; Bielecki JM; Krahn MD J Viral Hepat; 2021 May; 28(5):739-754. PubMed ID: 33556225 [TBL] [Abstract][Full Text] [Related]
32. Two Cases of Hepatocellular Carcinoma Arising Over 20 Years after a Sustained Virologic Response Following Interferon Therapy for Chronic Hepatitis C. Takata K; Ishii F; Uchida Y; Fukuda H; Yamauchi R; Umeda K; Tsuchiya N; Tanaka T; Yokoyama K; Morihara D; Takeyama Y; Shakado S; Sakisaka S; Hirai F Intern Med; 2020 Aug; 59(15):1855-1860. PubMed ID: 32350199 [TBL] [Abstract][Full Text] [Related]
33. Effect of achieving sustained virological response before hepatitis C virus-related hepatocellular carcinoma occurrence on survival and recurrence after curative surgical microwave ablation. Ryu T; Takami Y; Wada Y; Tateishi M; Matsushima H; Yoshitomi M; Mikagi K; Saitsu H Hepatol Int; 2018 Mar; 12(2):149-157. PubMed ID: 29488056 [TBL] [Abstract][Full Text] [Related]
34. The tertiary prevention of hepatocellular carcinoma in chronic hepatitis C patients. Huang JF; Yeh ML; Yu ML; Dai CY; Huang CF; Huang CI; Tsai PC; Lin PC; Chen YL; Chang WT; Hou NJ; Lin ZY; Chen SC; Chuang WL J Gastroenterol Hepatol; 2015 Dec; 30(12):1768-74. PubMed ID: 26094738 [TBL] [Abstract][Full Text] [Related]
35. A risk for hepatocellular carcinoma persists long-term after sustained virologic response in patients with hepatitis C-associated liver cirrhosis. Aleman S; Rahbin N; Weiland O; Davidsdottir L; Hedenstierna M; Rose N; Verbaan H; Stål P; Carlsson T; Norrgren H; Ekbom A; Granath F; Hultcrantz R Clin Infect Dis; 2013 Jul; 57(2):230-6. PubMed ID: 23616492 [TBL] [Abstract][Full Text] [Related]
36. Impact of virus eradication in patients with compensated hepatitis C virus-related cirrhosis: competing risks and multistate model. Petta S; Di Marco V; Bruno S; Enea M; Calvaruso V; Boccaccio V; Rossi S; Craxì A; Cammà C Liver Int; 2016 Dec; 36(12):1765-1773. PubMed ID: 27164508 [TBL] [Abstract][Full Text] [Related]
37. Effect of interferon therapy on the incidence of hepatocellular carcinoma and mortality of patients with chronic hepatitis C: a retrospective cohort study of 738 patients. Tanaka H; Tsukuma H; Kasahara A; Hayashi N; Yoshihara H; Masuzawa M; Kanda T; Kashiwagi T; Inoue A; Kato M; Oshima A; Kinoshita Y; Kamada T Int J Cancer; 2000 Sep; 87(5):741-9. PubMed ID: 10925370 [TBL] [Abstract][Full Text] [Related]
38. Dynamic risk assessment for hepatocellular carcinoma in patients with chronic hepatitis C. Lu M; Salgia R; Li J; Trudeau S; Rupp LB; Wu T; Daida YG; Schmidt MA; Gordon SC J Viral Hepat; 2023 Sep; 30(9):746-755. PubMed ID: 37415492 [TBL] [Abstract][Full Text] [Related]
39. Association between sustained virological response and all-cause mortality among patients with chronic hepatitis C and advanced hepatic fibrosis. van der Meer AJ; Veldt BJ; Feld JJ; Wedemeyer H; Dufour JF; Lammert F; Duarte-Rojo A; Heathcote EJ; Manns MP; Kuske L; Zeuzem S; Hofmann WP; de Knegt RJ; Hansen BE; Janssen HL JAMA; 2012 Dec; 308(24):2584-93. PubMed ID: 23268517 [TBL] [Abstract][Full Text] [Related]
40. Effects of a 24-week course of interferon-alpha therapy after curative treatment of hepatitis C virus-associated hepatocellular carcinoma. Jeong SC; Aikata H; Katamura Y; Azakami T; Kawaoka T; Saneto H; Uka K; Mori N; Takaki S; Kodama H; Waki K; Imamura M; Shirakawa H; Kawakami Y; Takahashi S; Chayama K World J Gastroenterol; 2007 Oct; 13(40):5343-50. PubMed ID: 17879404 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]